• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过保护间皮细胞免受癌细胞回缩的影响来抑制腹膜播散。

Suppression of peritoneal dissemination through protecting mesothelial cells from retraction by cancer cells.

作者信息

Hashimoto Shigenari, Takeoka Michiko, Taniguchi Shun'ichiro

机构信息

Department of Molecular Oncology, Division of Molecular and Cellular Biology, Institute on Aging and Adaptation, Shinshu University Graduate School of Medicine, Matsumoto, Japan.

出版信息

Int J Cancer. 2003 Nov 20;107(4):557-63. doi: 10.1002/ijc.11454.

DOI:10.1002/ijc.11454
PMID:14520692
Abstract

In a previous study, we demonstrated that calponin h1 suppressed tumor growth of transformed cells and that the peritonitis carcinomatosa induced by mouse B16-F10 melanoma (F10) cells was more extensive in calponin h1-deficient (CN(-/-)) mice with fragility of mesothelial (MS) cells than in their calponin h1-wild (CN(+/+)) counterparts. In our study, we assessed the therapeutic effect of calponin h1 on peritoneal dissemination. F10 cells were overlaid on the cultured CN(+/+) or CN(-/-) MS cells and the effect of calponin h1 on retraction of MS cells was evaluated. Then, an adenoviral vector with the calponin h1 gene (AdGFP-CN) inserted was constructed and was applied to CN(-/-) MS cells or CN(-/-) mouse peritoneum to investigate its suppressive effect on the peritoneal dissemination caused by F10 cells. Greater retraction and invasion of F10 cells were observed in CN(-/-) MS than in CN(+/+) cells in vitro, while down-regulation of calponin h1 was observed in CN(+/+) MS cells prior to the invasion of F10 cells. Infecting CN(-/-) MS cells with AdGFP-CN prevented their retraction and the invasion of F10 cells. Peritoneal dissemination was prominently suppressed in AdGFP-CN-infected CN(-/-) mice, and the survival of those mice was significantly prolonged. Thus, calponin h1 functioned to protect host MS cells from the invasion of F10 cells.

摘要

在先前的一项研究中,我们证明了钙调蛋白h1可抑制转化细胞的肿瘤生长,并且由小鼠B16-F10黑色素瘤(F10)细胞诱导的癌性腹膜炎在间皮(MS)细胞脆弱的钙调蛋白h1缺陷(CN(-/-))小鼠中比在其钙调蛋白h1野生型(CN(+/+))对应小鼠中更广泛。在我们的研究中,我们评估了钙调蛋白h1对腹膜播散的治疗效果。将F10细胞覆盖在培养的CN(+/+)或CN(-/-) MS细胞上,并评估钙调蛋白h1对MS细胞回缩的影响。然后,构建了插入有钙调蛋白h1基因的腺病毒载体(AdGFP-CN),并将其应用于CN(-/-) MS细胞或CN(-/-)小鼠腹膜,以研究其对F10细胞引起的腹膜播散的抑制作用。在体外观察到,CN(-/-) MS细胞中F10细胞回缩和侵袭比CN(+/+)细胞更明显,而在F10细胞侵袭之前,CN(+/+) MS细胞中钙调蛋白h1表达下调。用AdGFP-CN感染CN(-/-) MS细胞可阻止其回缩和F10细胞的侵袭。在AdGFP-CN感染的CN(-/-)小鼠中,腹膜播散得到显著抑制,这些小鼠的生存期显著延长。因此,钙调蛋白h1起到保护宿主MS细胞免受F10细胞侵袭的作用。

相似文献

1
Suppression of peritoneal dissemination through protecting mesothelial cells from retraction by cancer cells.通过保护间皮细胞免受癌细胞回缩的影响来抑制腹膜播散。
Int J Cancer. 2003 Nov 20;107(4):557-63. doi: 10.1002/ijc.11454.
2
Structural fragility of blood vessels and peritoneum in calponin h1-deficient mice, resulting in an increase in hematogenous metastasis and peritoneal dissemination of malignant tumor cells.钙调蛋白h1缺陷小鼠血管和腹膜的结构脆弱性,导致恶性肿瘤细胞血行转移和腹膜播散增加。
Cancer Res. 2001 Oct 15;61(20):7627-34.
3
Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells.腺病毒介导的钙调蛋白h1基因疗法针对卵巢癌腹膜播散:对腹膜细胞层和癌细胞的双功能治疗作用
Clin Cancer Res. 2006 Sep 1;12(17):5216-23. doi: 10.1158/1078-0432.CCR-06-0674.
4
Suppression of cancer phenotypes through a multifunctional actin-binding protein, calponin, that attacks cancer cells and simultaneously protects the host from invasion.通过一种多功能肌动蛋白结合蛋白钙调蛋白抑制癌症表型,该蛋白可攻击癌细胞并同时保护宿主免受侵袭。
Cancer Sci. 2005 Nov;96(11):738-46. doi: 10.1111/j.1349-7006.2005.00118.x.
5
Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expression.腺病毒载体介导的NK4表达对胃癌细胞腹膜种植的抑制作用
Cancer Gene Ther. 2005 Feb;12(2):206-16. doi: 10.1038/sj.cgt.7700782.
6
Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer.将可溶性Flt-1基因转导至腹膜间皮细胞可有效抑制胃癌的腹膜转移。
Cancer Res. 2004 May 15;64(10):3624-8. doi: 10.1158/0008-5472.CAN-04-0304.
7
Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin.通过过表达比基尼来抑制卵巢癌细胞系的侵袭和腹膜癌转移。
Int J Cancer. 2003 Apr 10;104(3):289-302. doi: 10.1002/ijc.10950.
8
Possible role of calponin h1 as a tumor suppressor in human uterine leiomyosarcoma.钙调蛋白h1作为人类子宫平滑肌肉瘤肿瘤抑制因子的潜在作用。
J Natl Cancer Inst. 1999 May 5;91(9):790-6. doi: 10.1093/jnci/91.9.790.
9
Role of H1-calponin in pancreatic AR42J cell differentiation into insulin-producing cells.H1-钙调蛋白在胰腺AR42J细胞分化为胰岛素分泌细胞中的作用。
Diabetes. 2003 Mar;52(3):760-6. doi: 10.2337/diabetes.52.3.760.
10
Identification of the Critical Site of Calponin 1 for Suppression of Ovarian Cancer Properties.鉴定钙调蛋白1抑制卵巢癌特性的关键位点。
Anticancer Res. 2015 Nov;35(11):5993-9.

引用本文的文献

1
miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway.miR-106b-5p 通过靶向 CNN1 并调节 Rho/ROCK1 通路促进乳腺癌肺转移。
Aging (Albany NY). 2020 Jan 27;12(2):1867-1887. doi: 10.18632/aging.102719.
2
Exceptional antineoplastic activity of a dendritic-cell-targeted vaccine loaded with a Listeria peptide proposed against metastatic melanoma.一种负载李斯特菌肽的靶向树突状细胞疫苗对转移性黑色素瘤具有卓越的抗肿瘤活性。
Oncotarget. 2016 Mar 29;7(13):16855-65. doi: 10.18632/oncotarget.7806.
3
Inhibition of adhesion and proliferation of peritoneally disseminated tumor cells by pegylated catalase.
聚乙二醇化过氧化氢酶对腹膜播散肿瘤细胞黏附和增殖的抑制作用
Clin Exp Metastasis. 2006;23(5-6):269-78. doi: 10.1007/s10585-006-9036-8. Epub 2006 Nov 3.
4
Suppression of cancer phenotypes through a multifunctional actin-binding protein, calponin, that attacks cancer cells and simultaneously protects the host from invasion.通过一种多功能肌动蛋白结合蛋白钙调蛋白抑制癌症表型,该蛋白可攻击癌细胞并同时保护宿主免受侵袭。
Cancer Sci. 2005 Nov;96(11):738-46. doi: 10.1111/j.1349-7006.2005.00118.x.